A Closer Look at Fatty Liver Disease and NASH
Date: 24 September 2020
Time: 3 PM PST | 5 PM CST | 11 PM BST
Did you know millions of people across the world are affected by a silent disease that is damaging their internal organs and often goes undetected until it is too late?
That’s why we’ve created LiverMultiScan®, an MRI-based assessment of liver tissue, to revolutionize the NASH clinical pathway and combat the rising burden of NAFLD / NASH.
In this webinar, we will discuss what challenges doctors face when identifying, treating and monitoring fatty liver disease, what role non-invasive patient-friendly tests play, and what support is available for patients suffering from fatty liver disease.
- The current challenges of NASH in clinical practice
- Integrating LiverMultiScan into the diagnostic pathway for NASH patients
- The importance of patient groups for support and recovery